-PEDIATRIC-
PREMIUM THESIS TOPICS

A haemoglobinopathy protocol is judged on internal consistency: the research question, objectives, methodology and statistical plan must all describe the same study. The primary objective should be a single measurable endpoint — one prevalence, one comparison, one association, one diagnostic accuracy estimate — with everything else demoted to secondary objectives. Beyond that, this subject has a small set of definitions that decide whether the thesis is defensible, and all of them belong in the protocol rather than in the discussion two years later.

State the genotype and how it was confirmed, and do not pool genotypes. Sickle cell anaemia, sickle cell–beta thalassaemia, haemoglobin E–beta thalassaemia and transfusion-dependent beta thalassaemia major have different haemoglobin levels, different crisis rates, different spleen behaviour and different transfusion requirements. A study that recruits "children with sickle cell disease" without stating whether compound heterozygotes were included produces means that describe no real group. Name the diagnostic method: solubility or sickling test is a screen and not a diagnosis, high-performance liquid chromatography is the working standard, and molecular confirmation is the reference where available. State the HbS, HbA2 and HbF cut-offs used and the analyser, since retention-time based reporting differs between platforms and co-eluting variants are a recognised source of misclassification.

Define the steady state, and define baseline haemoglobin. Most parameters on this list move with the child's clinical state. Specify that samples are drawn at least two to four weeks after a vaso-occlusive crisis, acute febrile illness, hospitalisation or transfusion, and exclude children who do not meet it rather than quietly including them. For a transfusion-dependent child, "haemoglobin" means the pre-transfusion trough value, measured immediately before the transfusion and stated as such; a post-transfusion sample measures the donor. Give the transfusion protocol the unit follows — the trigger level, the target, the interval — because the trough is a property of the unit's practice as much as of the disease.

Give severity an operational definition before registration. Around fifteen topics on this page use severity as an exposure or an outcome, and there is no single validated paediatric severity score in Indian practice. Choose an explicit definition — number of vaso-occlusive crises requiring hospital attendance in the preceding twelve months, transfusions per year, history of acute chest syndrome or stroke, or a published composite score cited by name — and state the recall window and the data source for each component. Parent recall and case records disagree, so say which one prevails and how discrepancies are resolved. A protocol that promises to classify severity without saying how invites the exact question at viva that cannot be answered afterwards.

Record treatment exposure, because it moves the variables being measured. Hydroxyurea raises foetal haemoglobin and mean corpuscular volume and reduces crisis frequency, so any HbF or severity topic must record whether the child is on it, at what dose and for how long, and either exclude or stratify. The same applies to chelation type and duration for every ferritin topic, to splenectomy for every spleen and haematology topic, and to folate and vitamin D supplementation for the micronutrient topics. Confounding by indication runs one way here: the sickest children are the ones started on treatment.

Name the growth reference and stage puberty. Anthropometry appears in roughly a quarter of these titles. State the reference used — the 2015 Indian Academy of Paediatrics charts or the WHO standards — and report Z-scores, not percentile bands, since Z-scores permit comparison and statistical testing. Height-for-age in an adolescent with thalassaemia is confounded by delayed puberty, so Tanner staging is mandatory in any growth topic covering children over about nine years, and bone age should be mentioned even if not obtainable. Say who measured, with what instrument, to what precision, and in duplicate.

Name the instrument for every scored outcome. Quality-of-life, adherence, caregiver burden, psychological morbidity and knowledge topics all rest on a questionnaire, and the choice of questionnaire is the study. State the instrument by name and version, whether the generic core or a disease module is used, the licence position, and the language: a translated tool needs forward and back translation with a documented cultural adaptation, and using an unvalidated in-house Hindi or Marathi rendering of a licensed scale is a common and avoidable weakness. Note the self-report age thresholds and who completed the proxy form, since parent-proxy and child self-report scores diverge systematically and must not be pooled into one mean.

A paediatrics synopsis is the condensed document of two to four pages — title, introduction, aim and objectives, brief methodology, sample size and references — submitted for registration of the dissertation topic. The paediatrics protocol is the expanded version of twelve to twenty pages carrying the full review of literature, detailed methodology including case definitions and laboratory methods, the instruments used with their reference ranges, the statistical plan, the study timeline and the annexures.

Four annexures carry particular weight on this subject. The case definition annexure should set out, in one table, exactly how each diagnosis and each clinical event is defined: genotype criteria with cut-offs, what counts as a vaso-occlusive crisis, what counts as a transfusion reaction, what counts as an episode of hospitalisation. The data collection proforma must include a transfusion and chelation history section — date of first transfusion, cumulative units or millilitres per kilogram, current interval, chelating agent and dose, documented gaps — because these fields are the ones residents discover missing after data collection has closed. The instrument annexure reproduces the questionnaire with its scoring key and carries the permission or licence correspondence. And the consent set requires both a parent or guardian information sheet and consent form, and a separate age-appropriate assent form in the local language for the older child.

Two things distinguish a paediatric protocol from an adult one and examiners look for both. The methodology must state the age range in completed years or months with the upper limit defined, and it must handle the child who turns older, or transitions to adult care, during the study period. And where blood is drawn, the maximum volume must be stated with reference to the child's weight, along with a statement that no sample is taken for research alone if a clinical sample is already being collected.

In practice the synopsis is extracted from the protocol rather than written separately, which is faster and produces a more coherent document. Check the university's prescribed proforma before submission, since rejections on formatting grounds are common and entirely avoidable.

Match the formula to the design. Prevalence topics — growth failure, microalbuminuria, alloimmunisation, thyroid dysfunction, vitamin D deficiency — use a single proportion formula with an expected prevalence taken from a cited comparable study, and where the finding is uncommon use relative rather than absolute precision or the sample collapses to an implausible number. Comparative topics need a two-mean or two-proportion calculation with both expected values referenced. Correlation topics size on the expected correlation coefficient. Say which citation supplied the input figure; an unreferenced expected prevalence is the commonest reason a sample size calculation is sent back.

Take the prevalence input from Indian data, not from African or Mediterranean series. Sickle cell disease in central India runs a milder course than the classical descriptions, because of the Arab-Indian haplotype with its higher foetal haemoglobin and the frequent coexistence of alpha thalassaemia. Crisis rates, stroke rates and splenic sequestration figures imported from West African or American cohorts will overestimate events and produce a sample size that cannot be met. The same caution applies in reverse to thalassaemia trait prevalence, which varies sharply between communities within a single district.

The diagnostic topics need diagnostic-study sizing and paired comparison, not a group-comparison approach. Mentzer index, red cell distribution width and the other discriminant indices are sized on the expected sensitivity and specificity with a stated precision, and the number required is the number of children with the trait, from which the total is derived using the expected prevalence in the microcytic population being screened — not the other way round. Because every index is computed from the same complete blood count on the same child, comparing them is a comparison of correlated tests: use paired methods and compare areas under the receiver operating characteristic curve by DeLong's method rather than testing each index against the reference separately and declaring the largest number the winner. Report sensitivity, specificity, predictive values and likelihood ratios with confidence intervals, and remember that the predictive values belong to the prevalence in that clinic and travel badly.

The reference standard in the trait studies fails on the same children the index test fails on. HbA2 above the accepted threshold on high-performance liquid chromatography is the reference standard for beta thalassaemia trait in almost every one of these topics, and coexisting iron deficiency lowers HbA2, sometimes below the cut-off. In an Indian paediatric population, iron deficiency is present in a large proportion of exactly the microcytic children being screened. So the protocol must state the HbA2 cut-off used, must include iron studies rather than assuming iron status, and should state what happens to a borderline HbA2 result in an iron-deficient child — ideally repeat testing after iron repletion, or classification as indeterminate rather than negative. A study that does not address this will report an artificially low trait prevalence and an artificially good performance for whichever index it favours.

Ferritin needs care as a variable. It is right-skewed, so summarise it as median with interquartile range and either log-transform before parametric testing or use non-parametric tests throughout. It is an acute-phase reactant, so a concurrent C-reactive protein and an explicit exclusion of intercurrent infection belong in the methods. And it is a weak proxy for tissue iron: it tracks liver iron loosely and cardiac iron poorly, so a study associating ferritin with echocardiographic or endocrine findings should state that limitation in the protocol rather than concluding more than the measurement supports. Where the unit has access to T2-star magnetic resonance imaging, say so; where it does not, say that too.

Plan for confounding and for multiplicity. These are cross-sectional studies, so an association is not a sequence: ferritin measured today and short stature measured today cannot establish which came first, and the objective should be worded as association rather than effect. Where the analysis carries more than a handful of comparisons — a panel of endocrine tests, a battery of quality-of-life subscales — nominate the primary endpoint in advance and treat the rest as exploratory, or apply a stated correction. Adjust for the obvious confounders by multivariable regression: age, sex, socio-economic status, genotype, transfusion frequency and hydroxyurea or chelation exposure, entered because they are clinically justified rather than because they reached significance on univariate screening.

Name the tests. Continuous variables are summarised as mean with standard deviation where normally distributed and median with interquartile range otherwise, with normality formally tested. Two independent groups use the t-test or Mann-Whitney U test, three or more groups analysis of variance or the Kruskal-Wallis test with a stated post-hoc correction. Proportions use the chi-squared test with Fisher's exact test for sparse cells. Correlation uses Pearson where both variables are normally distributed and Spearman otherwise. For record-based components, state in advance how missing data are handled and report the number of records excluded for incompleteness, since selective exclusion is itself a bias.

Start from the register, not from the literature. Count how many children with each genotype actually attend the unit in a year: the thalassaemia day-care list gives an exact denominator, the sickle cell clinic register gives another, and the two are rarely the size a resident assumes. A topic needing eighty children with transfusion-dependent beta thalassaemia is straightforward in a district with a large day-care unit and impossible in one that follows twenty-two.

Then check what the laboratory already does routinely and at what cost to whom. High-performance liquid chromatography, ferritin, thyroid function, vitamin D, zinc, microalbumin and echocardiography differ enormously in availability, and a test that must be purchased for the study needs a funding line in the protocol and usually a justification to the ethics committee. Topics built entirely on the haemogram, the HPLC report and the transfusion register are the ones that finish on time. Confirm before choosing whether the unit has an established sickle cell programme, since screening-related topics depend on it.

Descriptive clinical and haematological profiles remain the most common and are readily accepted: a defined cohort of children with a stated genotype, described across clinical, laboratory and anthropometric parameters. Prevalence studies of a complication within a disease group, comparative studies between two genotypes or against healthy controls, and analytical studies associating a laboratory value with a clinical outcome are all established designs.

Diagnostic accuracy studies form their own category here and publish well, since discriminant indices against high-performance liquid chromatography have direct application in screening. Questionnaire-based studies of quality of life, adherence, caregiver burden and knowledge are accepted and are often the most feasible option where laboratory support is limited, provided a validated instrument is used properly. Prospective observational follow-up over the thesis period is possible for transfusion reactions and crisis frequency, but the cross-sectional framing on this list is chosen deliberately, because it fits the time available between ethics clearance and submission.

Bring three to five shortlisted titles rather than one, since guides frequently rule out a topic on grounds a new resident cannot see — a senior resident already holding the thalassaemia register, a departmental project on the same clinic, a laboratory contract about to lapse.

Settle six things in that meeting: how many children of the required genotype attend annually and how the denominator was counted, which investigations are free to the patient and which must be funded, whether the transfusion register and case records actually contain the transfusion and chelation history the protocol will need, who in pathology or the blood bank will run the samples and whether they have agreed in writing, which questionnaire will be used and whether a licence and a validated local-language version exist, and which journal the eventual paper is aimed at. Where a topic requires echocardiography, endocrinology review or blood bank antibody screening, secure that cooperation formally rather than on an informal understanding, because these are the collaborations that fail quietly in month seven.

Many can, and record-based work is often the only way to assemble adequate numbers of an uncommon genotype in a single thesis period. State the archive period, how records were identified, and the exclusion criteria, and apply for a waiver of consent explicitly rather than assuming one follows automatically from the design.

Three cautions. Completeness decides the study. Retrieve twenty records before writing the protocol and check whether the fields the analysis needs are actually recorded — pre-transfusion haemoglobin, cumulative transfusion volume, chelation dose and gaps, Tanner stage, height measured rather than stated. Whatever is missing in that sample will be missing in the whole series. Records capture attendance, not disease. Children who attend regularly are not representative of all children with the condition, and crisis counts drawn from hospital records omit crises managed at home or elsewhere, which biases severity downward. Say so. Anthropometry rarely survives. Height is frequently absent or copied forward from an earlier visit, so a retrospective growth study is often better converted into a prospective measurement study on the same clinic population, which costs nothing but time.

The synopsis is the condensed two to four page document submitted for topic registration. The protocol is the full document of twelve to twenty pages containing the detailed review of literature, methodology with case definitions and laboratory methods, the instruments and their reference ranges, the statistical plan, the timeline and the annexures including the data collection proforma and the consent and assent set. The synopsis is normally extracted from the completed protocol.

Institutional ethics committee approval before any data collection, under the national ethical guidelines for biomedical research involving human participants and, for children, the specific provisions governing paediatric research.

Consent and assent. Written informed consent is taken from a parent or legal guardian, and written assent is additionally taken from the child from about seven years of age, in an age-appropriate document in the local language. Both forms belong in the annexures. State that participation is voluntary, that refusal does not affect the child's transfusions or clinical care, and that the child may decline even where the parent has consented.

No research-only blood, and a stated volume limit. These children are already venepunctured frequently. Wherever possible the study should use the residual sample from an investigation already being drawn for clinical reasons, and the protocol should say so explicitly. Where an additional sample is unavoidable, state the volume, justify it, and set it against the permitted limit for the child's weight. The same principle rules out any imaging or radiation performed for research alone; only studies already indicated clinically may be used.

Incidental findings need a named pathway, and here they are predictable. A transfusion-transmitted infection study will find positive results for hepatitis B, hepatitis C or HIV in some children, and the protocol must state in advance who is informed, how, by whom, and how the child is linked to treatment — not that results will merely be reported in the thesis. Endocrine and cardiac screening topics will detect previously unrecognised abnormalities and need a referral pathway stated the same way. Psychological screening will identify children with significant distress, and a route to counselling must be named.

Genetic and family implications. Testing that identifies carrier status in a child carries information about the parents and siblings that they did not ask for, and occasionally about paternity. State how results are communicated, that genetic counselling is offered rather than merely mentioned, and how confidentiality within the family is handled. Photographs of children require separate written consent and identifiable facial images should be avoided altogether. No topic on this page requires knowledge of the sex of a foetus; prenatal diagnosis for a haemoglobinopathy is lawful in India, but disclosure of foetal sex is prohibited under the Pre-Conception and Pre-Natal Diagnostic Techniques Act, and no dissertation may record or report it.

Clearance commonly takes six to ten weeks and retrospective approval is not granted.

Not on a post-transfusion sample, and this is the single most common fatal flaw in a paediatric haemoglobinopathy thesis. Transfused red cells are the donor's, and for roughly the next three months the child's blood is a mixture. Every measurement that comes from the red cell — the high-performance liquid chromatography pattern, HbA2, HbF, HbS percentage, mean corpuscular volume, red cell distribution width, every discriminant index built from them — is diluted by normal donor cells and shifted towards normal. HbA2 can fall below the diagnostic threshold, HbS can be reported at a fraction of its true proportion, and a genuine trait or compound heterozygote can be reported as normal. The practical rule is that the diagnostic sample must be drawn before the first transfusion, or at least three months after the last, and the protocol should state the interval used and record the date of the last transfusion for every child. In a transfusion-dependent thalassaemic that window essentially never opens, so the diagnosis must rest on the pre-transfusion HPLC done at first presentation, retrieved from the record, or on parental HPLC showing both parents as carriers, or on molecular testing — not on a fresh sample taken during the study. Three consequences follow for the topics on this page. Diagnostic and variant-pattern topics must recruit before transfusion, which in practice means recruiting from the anaemia clinic and the screening pathway rather than from the day-care unit. Index studies must exclude any child transfused within three months and say how many were excluded on that ground. Studies of established transfusion-dependent patients should take the genotype from the record and measure only what transfusion does not distort — ferritin, growth, organ function, quality of life — with pre-transfusion trough haemoglobin used wherever haemoglobin is required. Stating this rule in the methodology is also the fastest way to demonstrate to an examiner that the study was designed by someone who understood the material.

Substantially. A PhD proposal typically runs 6,000 to 10,000 words and carries an extended critical literature review, a theoretical framework, a detailed methodology chapter and a discussion of expected contribution to the field. An MD synopsis is a two to four page registration document. The research question can be the same; the depth expected is not.

Most universities require registration within six to nine months of joining. Shortlist in the first two months, finalise with the guide by the third, and file for ethics clearance immediately afterwards. Recruitment in this subject is slower than residents expect, because eligible children attend on fixed transfusion days, steady-state and post-transfusion interval criteria disqualify a proportion at each visit, and questionnaire sessions with a parent take longer than a case record entry. Close the data collection window at least six months before submission.